Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Autoimmune Encephalitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Christian Geis, Prof.

    Study Director

    University Hospital Jena